A Study of ApricityRx™ for Management of IR-AEs in Patients on Immuno-Oncology Therapy
Clinical trial NCT04571398 · UNKNOWN
Trial details
- NCT number
- NCT04571398
- Sponsor
- Apricity Health, Inc
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2019-11-19
- Primary completion
- 2022-10-15
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.